These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 1384787)
1. Phenotypic heterogeneity of primitive leukemic hematopoietic cells in patients with chronic myeloid leukemia. Udomsakdi C; Eaves CJ; Lansdorp PM; Eaves AC Blood; 1992 Nov; 80(10):2522-30. PubMed ID: 1384787 [TBL] [Abstract][Full Text] [Related]
2. Characterization of primitive hematopoietic cells in normal human peripheral blood. Udomsakdi C; Lansdorp PM; Hogge DE; Reid DS; Eaves AC; Eaves CJ Blood; 1992 Nov; 80(10):2513-21. PubMed ID: 1384786 [TBL] [Abstract][Full Text] [Related]
3. Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level. Udomsakdi C; Eaves CJ; Swolin B; Reid DS; Barnett MJ; Eaves AC Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6192-6. PubMed ID: 1631107 [TBL] [Abstract][Full Text] [Related]
4. The biology of normal and neoplastic stem cells in CML. Eaves C; Udomsakdi C; Cashman J; Barnett M; Eaves A Leuk Lymphoma; 1993; 11 Suppl 1():245-53. PubMed ID: 8251904 [TBL] [Abstract][Full Text] [Related]
5. BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients. Verfaillie CM; Bhatia R; Miller W; Mortari F; Roy V; Burger S; McCullough J; Stieglbauer K; Dewald G; Heimfeld S; Miller JS; McGlave PB Blood; 1996 Jun; 87(11):4770-9. PubMed ID: 8639848 [TBL] [Abstract][Full Text] [Related]
6. Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia. Petzer AL; Eaves CJ; Lansdorp PM; Ponchio L; Barnett MJ; Eaves AC Blood; 1996 Sep; 88(6):2162-71. PubMed ID: 8822936 [TBL] [Abstract][Full Text] [Related]
7. Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation. Bhatia R; Munthe HA; Williams AD; Zhang F; Forman SJ; Slovak ML Exp Hematol; 2000 Dec; 28(12):1401-12. PubMed ID: 11146162 [TBL] [Abstract][Full Text] [Related]
8. BCR-ABL expression in different subpopulations of functionally characterized Ph+ CD34+ cells from patients with chronic myeloid leukemia. Maguer-Satta V; Petzer AL; Eaves AC; Eaves CJ Blood; 1996 Sep; 88(5):1796-804. PubMed ID: 8781437 [TBL] [Abstract][Full Text] [Related]
9. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver. Roy V; Miller JS; Verfaillie CM Exp Hematol; 1997 May; 25(5):387-94. PubMed ID: 9168060 [TBL] [Abstract][Full Text] [Related]
10. Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia. Bernstein ID; Singer JW; Smith FO; Andrews RG; Flowers DA; Petersens J; Steinmann L; Najfeld V; Savage D; Fruchtman S Blood; 1992 Apr; 79(7):1811-6. PubMed ID: 1373089 [TBL] [Abstract][Full Text] [Related]
11. Selective expansion of primitive normal hematopoietic cells in cytokine-supplemented cultures of purified cells from patients with chronic myeloid leukemia. Petzer AL; Eaves CJ; Barnett MJ; Eaves AC Blood; 1997 Jul; 90(1):64-9. PubMed ID: 9207439 [TBL] [Abstract][Full Text] [Related]
12. Biological strategies for the selective manipulation of normal and leukemic stem cells. Eaves CJ; Cashman JD; Zoumbos NC; Barnett MJ; Eaves AC Stem Cells; 1993 Oct; 11 Suppl 3():109-21. PubMed ID: 7905319 [TBL] [Abstract][Full Text] [Related]
13. Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Verfaillie CM; Miller WJ; Boylan K; McGlave PB Blood; 1992 Feb; 79(4):1003-10. PubMed ID: 1371077 [TBL] [Abstract][Full Text] [Related]
14. BCR/ABL- CD34(+)HLA-DR- progenitor cells in early chronic phase, but not in more advanced phases, of chronic myelogenous leukemia are polyclonal. Delforge M; Boogaerts MA; McGlave PB; Verfaillie CM Blood; 1999 Jan; 93(1):284-92. PubMed ID: 9864172 [TBL] [Abstract][Full Text] [Related]
15. Granulocyte-macrophage colony-stimulating factor modulation of the inhibitory effect of transforming growth factor-beta on normal and leukemic human hematopoietic progenitor cells. Cashman JD; Eaves AC; Eaves CJ Leukemia; 1992 Sep; 6(9):886-92. PubMed ID: 1518302 [TBL] [Abstract][Full Text] [Related]
16. Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages. Bhatia R; McGlave PB; Dewald GW; Blazar BR; Verfaillie CM Blood; 1995 Jun; 85(12):3636-45. PubMed ID: 7780147 [TBL] [Abstract][Full Text] [Related]
17. Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor. Prosper F; Stroncek D; Verfaillie CM Blood; 1996 Sep; 88(6):2033-42. PubMed ID: 8822922 [TBL] [Abstract][Full Text] [Related]
19. Contact with fibronectin enhances preservation of normal but not chronic myelogenous leukemia primitive hematopoietic progenitors. Bhatia R; Williams AD; Munthe HA Exp Hematol; 2002 Apr; 30(4):324-32. PubMed ID: 11937267 [TBL] [Abstract][Full Text] [Related]
20. Primitive long-term culture initiating cells (LTC-ICs) in granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells have similar potential for ex vivo expansion as primitive LTC-ICs in steady state bone marrow. Prosper F; Vanoverbeke K; Stroncek D; Verfaillie CM Blood; 1997 Jun; 89(11):3991-7. PubMed ID: 9166837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]